🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Sezary Syndrome

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. NCT04904146n/a1 site📍 Lund Lund University Hospital · Tests: Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profil… A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab NCT07003100n/a10 sites📍 Duarte📍 Palo Alto📍 Tampa City of Hope Medical Center · Tests: Non-Interventional Study A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma NCT06436677n/a3 sites📍 Beijing📍 Beijing📍 Beijing Peking University First Hospital · Tests: molecular subtype based treatment Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Pembrolizumab, Mogamulizumab Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma NCT04234048Phase 110 sites📍 Scottsdale📍 Duarte📍 Los Angeles SciTech Development, Inc. · Tests: Fenretinide Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance NCT07132567n/a6 sites📍 Busan📍 Seoul📍 Seoul Kyowa Kirin Co., Ltd. · Tests: Poteligeo 20mg Extracorporeal Photopheresis in Sezary Syndrome NCT05157581n/a3 sites📍 Atlanta📍 Baltimore📍 Pittsburgh Oleg E. Akilov, MD, PhD · Tests: Extracorporeal photopheresis (ECP), Methoxsalen Injection A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653Phase 215 sites📍 Duarte📍 Irvine📍 New Haven Prescient Therapeutics, Ltd. · Tests: PTX-100 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research NCT00177268n/a1 site📍 Pittsburgh University of Pittsburgh · Tests: Blood draw, skin biopsy or urine collection A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites📍 Duarte📍 San Diego📍 San Francisco Memorial Sloan Kettering Cancer Center · Tests: Optional Blood Sample and Nail Sample Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma NCT03011814Phase 1, Phase 24 sites📍 Duarte📍 New York📍 Philadelphia City of Hope Medical Center · Tests: Durvalumab, Laboratory Biomarker Analysis, Lenalidomide A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma NCT07192471Phase 122 sites📍 Duarte📍 Orange📍 Stanford Kyowa Kirin, Inc. · Tests: KK2223 Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients NCT03587844Phase 28 sites📍 Stanford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: brentuximab vedotin, brentuximab vedotin, brentuximab vedotin ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome NCT02848274n/a13 sites📍 Duarte📍 Palo Alto📍 Iowa City Stanford University Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma NCT06588868n/a18 sites📍 Ancona📍 Bari📍 Bari Fondazione Italiana Linfomi - ETS Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome NCT04256018Phase 21 site📍 Stanford Stanford University · Tests: Mogamulizumab, LD TSEBT Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653Phase 23 sites📍 Scottsdale📍 Duarte📍 Atlanta City of Hope Medical Center · Tests: Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment, Questionnaire Administration Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL NCT06382844n/a1 site📍 Salamanca Instituto de Investigación Biomédica de Salamanca · Tests: Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS). Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy